Home > Products > Specialty & Industrial Chemicals > Specialty Chemicals > 2-CHLORO-5-NITRO-N-4-PYRIDINYLBENZAMIDE
2-CHLORO-5-NITRO-N-4-PYRIDINYLBENZAMIDE structure, CAS 313516-66-4

2-CHLORO-5-NITRO-N-4-PYRIDINYLBENZAMIDE

CAS Number313516-66-4

Synonyms2-Chloro-5-nitro-N-4-pyridinyl-benzamide Benzamide,2-chloro-5-nitro-N-4-pyridinyl; Benzamide,2-chloro-5-nitro-N-4-pyridinyl; 2-chloro-5-nitro-N-pyridin-4-yl-benzamide; 2-Chloro-5-nitro-N-(4-pyridinyl)benzamide; 2-Chloro-5-nitro-N-4-pyridinylbenzamide; 2-chloro-5-nitro-N-(pyridin-4-yl)benzamide; T0070907

Molecular FormulaC12H8ClN3O3

Molecular Weight277.66

Purity≥98 (HPLC)%

Density1.5±0.1 g/cm3

Boiling Point381.7±37.0 °C at 760 mmHg

Melting Point

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symboltransportation

Signal WordWarning

Cat. No.: 2A-9091067 Purity: ≥98 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 313516-66-4 ] Purity: ≥98 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number313516-66-4
Catalog No.2A-9091067
Chinese NameT0070907
Synonyms2-Chloro-5-nitro-N-4-pyridinyl-benzamide Benzamide,2-chloro-5-nitro-N-4-pyridinyl; Benzamide,2-chloro-5-nitro-N-4-pyridinyl; 2-chloro-5-nitro-N-pyridin-4-yl-benzamide; 2-Chloro-5-nitro-N-(4-pyridinyl)benzamide; 2-Chloro-5-nitro-N-4-pyridinylbenzamide; 2-chloro-5-nitro-N-(pyridin-4-yl)benzamide; T0070907
Molecular FormulaC12H8ClN3O3
Molecular Weight277.66
Purity≥98 (HPLC)
Density1.5±0.1 g/cm3
Boiling Point381.7±37.0 °C at 760 mmHg
Appearancepowder
Water SolubilityDMSO: >10mg/mL | Soluble in DMSO at 10mg/ml. Insol
Storage ConditionStore at RT
ApplicationT0070907 is a potent PPARγ antagonist with a Ki value of 1 nM.
HTC2933399090
PubChem ID329826884
MDL NumberMFCD00121849
SMILES[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccncc2
InChI1S/C12H8ClN3O3/c13-11-2-1-9(16(18)19)7-10(11)12(17)15-8-3-5-14-6-4-8/h1-7H,(H,14,15,17)
InChI KeyFRPJSHKMZHWJBE-UHFFFAOYSA-N
NACRES CodeNA.77
UNSPSC12352203
Hazard Symbolstransportation
MSDSmsds/91067_1_313516_66_4.pdf
BioactivityT0070907 is a potent PPARγ antagonist with a Ki of 1 nM. Related Catalog Signaling Pathways >> Cell Cycle/DNA Damage >> PPAR Signaling Pathways >> Cell Cycle/DNA Damage >> RAD51 Research Areas >> Cancer Target PPARγ:1 nM (Ki) PPARδ:1.8 μM (Ki) PPARα:0.85 μM (Ki) In Vitro T0070907 (50 μM) pre-treatment impairs repair of IR-induced DNA DSBs in both ME-180 and SiHa cells treated with irradiated (4 Gy). T0070907 (0-50 μM) significantly decreases the levels of DNA-PKcs and RAD51 proteins in ME-180 and SiHa cells[1]. T0070907 (50 μM) treatment reduces the levels of α- and β-tubulin protein in a time-dependent manner, decreases the synthesis of DNA, and prevents the radiation-induced alterations in the cell cycle regulatory proteins of ME180 and SiHa cells[2]. T0070907 (10 µM) has cytotoxicity in an adipocyte-specific and PPARγ-independent manner. T0070907 increases oxidative stress in immature adipocytes[3]. T0070907 (1 μM) blocks the induction of adipogenesis by various treatments of the adipogenic cell line 3T3-L1. T0070907 covalently modifies PPAR on cysteine 313 in helix 3 of human PPAR 2[4]. Kinase Assay To determine the binding affinity of T0070907 to the PPARs, scintillation proximity assay (SPA) is performed with the following modifications. A 90 μL reaction contains SPA buffer (10 mM K2HPO4, 10 mM KH2PO4, 2 mM EDTA, 50 mM NaCl, 1 mM dithiothreitol, 2 mM CHAPS, 10% (v/v) glycerol, pH 7.1), 50 ng of GST-PPAR (or 150 ng of GST-PPAR), 5 nM 3H-labeled radioligands, and 5 μL of T0070907 in Me2SO. After incubation for 1 h at room temperature, 10 μL of polylysine-coated SPA beads (at 20 mg/mL in SPA buffer) are added, and the mixture is incubated for 1 h before reading in Packard Topcount. [3H]Rosiglitazone is used for PPAR, and [3H]GW2433 is used for PPAR and PPAR. References [1]. An Z, et al. T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51. Toxicol In Vitro. 2016 Dec;37:1-8 [2]. An Z, et al. T0070907, a PPAR γ inhibitor, induced G2/M arrest enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. Reprod Sci. 2014 Nov;21(11):1352-61. [3]. Kawahara A, et al. Peroxisome proliferator-activated receptor γ (PPARγ)-independent specific cytotoxicity against immature adipocytes induced by PPARγ antagonist T0070907. Biol Pharm Bull. 2013;36(9):1428-34 [4]. Lee G, et al. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem. 2002 May 31;277(22):19649-57. Epub 2002 Mar 4 Chemical & Physical Properties Density 1.5±0.1 g/cm3 Boiling Point 381.7±37.0 °C at 760 mmHg Molecular Formula C12H8ClN3O3 Molecular Weight 277.663 Flash Point 184.6±26.5 °C Exact Mass 277.025421 PSA 87.81000 LogP 2.25 Appearance of Characters white Vapour Pressure 0.0±0.9 mmHg at 25°C Index of Refraction 1.684 Storage condition Store at RT Water Solubility DMSO: >10mg/mL | Soluble in DMSO at 10mg/ml. Insoluble in water.
Use ofT0070907 is a potent PPARγ antagonist with a Ki of 1 nM. Properties Articles12 Name 2-chloro-5-nitro-N-pyridin-4-ylbenzamide Synonym More Synonyms T0070907 Biological Activity Description T0070907 is a potent PPARγ antagonist with a Ki of 1 nM. Related Catalog Signaling Pathways >> Cell Cycle/DNA Damage >> PPAR Signaling Pathways >> Cell Cycle/DNA Damage >> RAD51 Research Areas >> Cancer PPARγ:1 nM (Ki) PPARδ:1.8 μM (Ki) PPARα:0.85 μM (Ki) References [1]. An Z, et al. T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51. Toxicol In Vitro. 2016 Dec;37:1-8 [3]. Kawahara A, et al. Peroxisome proliferator-activated receptor γ (PPARγ)-independent specific cytotoxicity against immature adipocytes induced by PPARγ antagonist T0070907. Biol Pharm Bull. 2013;36(9):1428-34 [4]. Lee G, et al. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem. 2002 May 31;277(22):19649-57. Epub 2002 Mar 4 Chemical & Physical Properties Exact Mass 277.025421 PSA 87.81000 Appearance of Characters white Index of Refraction 1.684 Storage condition Store at RT
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Purity: 99.0%
MSDS Transport InfoModule 14. Shipping information 14.1 UN number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: No dangerous goods IMDG Code: No dangerous goods International Air Transport Dangerous Regulations: No dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special precautions for users No data available
Related Products in Specialty Chemicals
N,N-DIETHYL-N'-1-NAPHTHYLETHYLENEDIAMINEOXALATE74474-31-02A-9091058
2-(4-BROMOPHENYL)-1,1-DIPHENYLETHYLENE18648-66-32A-9091063
(1H-PYRROL-2-YL)METHANAMINE64608-72-62A-9091064
"Benzenamine,4-fluoro-2-(1-methylethoxy)- "148583-65-72A-9091065
"4-FLUORO-2-ISOPROPOXYANILINEHYDROCHLORIDE "380430-47-72A-9091066
SELEGILINE14611-51-92A-9091069
87639-57-487639-57-42A-9091070
6-methyl-2-(methylamino)nicotinicacid155790-12-82A-9091072
3-(pyridin-2-yloxy)propan-1-amine125767-31-92A-9091073
HYODEOXYCHOLICACIDSODIUMSALT10421-49-52A-9091074
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA